Printer Friendly

COMPANY INFORMATION
DiaMedica Inc. 8-1250 Waverley St Winnipeg, MB R3T 6C6 Tel: (204) 487-3806 Fax: (204) 453-3745 Contact Name Kevin B. Richardson Industry Biotechnology		Key Executives Rick Pauls, acting CEO Eric R. Johnstone, v-p, fin. Discovers and develops drugs for the treatment of Type 2 diabetes.
FP ADVISOR COVERAGE DiaMedica Inc. • FP Corporate Surveys • FP Directory of Directors • Ordering FP Products		TOP INDUSTRY PLAYERS Biotechnology Company Name Revenue ($000s)  Atrium Innovations Inc. 309,546 Angiotech Pharmaceuticals, Inc. 302,251 QLT Inc. 132,457 Oncothyreon Inc. 42,678 AEterna Zentaris Inc. 41,056 (Links are to Snapshots.)
FINANCIAL RATIOS AS OF FEB 8/10 Listed Close 52-wk High 52-wk Low IAD Latest Dividend Yield 60-mo Beta TSX-VEN/DMA $0.64 $1.10 $0.35 n.a. n.a. n.a. n.a. Avg 20-day Volume P/E 12-mo EPS EPS Date 1-yr Return 3-yr Return 5-yr Return Market Cap. (000s) 5,532 n.a. $-0.14 June 30/09 -28.89% n.a. n.a. $12,294
ANNUAL FINANCIALS Periods ended: 12m Dec. 31/08 12m Dec. 31/07 12m Dec. 31/06 $000s $000s $000s Net income (2,256) (2,311) (907) Total assets 3,648 4,295 824 $ $ $ Earnings per share* (0.12) (0.14) (0.09) % % % Return on equity (60.91) (208.76) n.m.   * Common

COMPANY NEWS

Results for 'DiaMedica Inc.' from past 30 days: No hits. (Links are to articles.)